MedTrace Logo

Intra-arterial Versus Intravenous Chemotherapy for Locally Advanced Pancreatic Cancer

NCT02635971 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 168

Last updated 2020-03-05

No results posted yet for this study

Summary

This study aims to explore the efficacy and safety of intra- arterial infusion of gemcitabine and oxaliplatin in locally advanced pancreatic cancer. This protocol is overseen by the Fudan University Institutional Review Board which has Federal Wide Assurance through the U.S. Department of Health \& Human Services (Approved: April 25, 2002).

Conditions

  • Carcinoma, Pancreatic

Interventions

PROCEDURE

Transcatheter arterial infusion

PROCEDURE

Intravenous chemotherapy

DRUG

Gemcitabine

DRUG

Oxaliplatin

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Principal Investigators

  • Zhiqiang Meng, MD, Ph D · Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2022-06-30
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02635971 on ClinicalTrials.gov